Favorable response of chronic refractory immune thrombocytopenic purpura to mesenchymal stem cells - Wikidata - wikimedia - TriplyDB

Favorable response of chronic refractory immune thrombocytopenic purpura to mesenchymal stem cells

Favorable response of chronic refractory immune thrombocytopenic purpura to mesenchymal stem cells

http://www.wikidata.org/entity/Q33395970

about

Platelet-Derived Growth Factor-BB Protects Mesenchymal Stem Cells (MSCs) Derived From Immune Thrombocytopenia Patients Against Apoptosis and Senescence and Maintains MSC-Mediated Immunosuppression.Intravenous infusion umbilical cord-derived mesenchymal stem cell in primary immune thrombocytopenia: A two-year follow-up.A Prospective, Nonrandomized, no Placebo-Controlled, Phase I/II Clinical Trial Assessing the Safety and Efficacy of Intramuscular Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in Patients With Severe Buerger's Disease Adipose-derived stem cells: Implications in tissue regeneration.Are They Really Stem Cells? Scrutinizing the Identity of Cells and the Quality of Reporting in the Use of Adipose Tissue-Derived Stem Cells.Different isolation methods alter the gene expression profiling of adipose derived stem cells.Stem cells show promising results for lymphoedema treatment--a literature review.Concise Review: A Safety Assessment of Adipose-Derived Cell Therapy in Clinical Trials: A Systematic Review of Reported Adverse Events.Off-label use of adipose-derived stem cells.

P2860

Q33434245-0262123B-66F8-4CB6-AC73-3A3B725E520E Q33442285-E4194E40-9149-4A52-B13B-7B7A4336BE2A Q33901995-53B5CAF6-011B-4ED6-907B-303D0293704C Q34038848-6F5885F3-E0DE-47B5-BA3C-E91C982C03FB Q36427302-CB1F6630-FA99-4F8E-ADBB-5960401DFF84 Q37660805-8AE5BA30-0EFC-4C2A-B54F-D46DD0B3FB6E Q38255872-24EB1853-4264-4974-B64A-D30874299B0E Q38655379-32F0B668-5EA7-41DC-94C1-19B452AF2629 Q45913602-A86540A5-0A6B-4D11-835C-4023BAD1E502

P2860

Favorable response of chronic refractory immune thrombocytopenic purpura to mesenchymal stem cells

http://www.wikidata.org/entity/Q33395970

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Favorable response of chronic ...... pura to mesenchymal stem cells

@ast

Favorable response of chronic ...... pura to mesenchymal stem cells

@en

type

label

Favorable response of chronic ...... pura to mesenchymal stem cells

@ast

Favorable response of chronic ...... pura to mesenchymal stem cells

@en

prefLabel

Favorable response of chronic ...... pura to mesenchymal stem cells

@ast

Favorable response of chronic ...... pura to mesenchymal stem cells

@en

P1433

Q33395970-4C19605E-A0E5-4056-BCBB-26CD42D33F7B

P1476

Q33395970-1A08166C-5A7F-4972-83DA-EF1E15BA7734

P2093

Q33395970-0207B386-E992-4366-B76A-CAC124945D62

Q33395970-6C122904-783E-45C3-8A52-B0AAE15B18FE

Q33395970-73455B20-AC5F-455D-B196-F3ADCF2FEB74

Q33395970-B7B63DB9-0767-45FA-AF76-6FBDA9D0CD8F

P2860

Q33395970-0259E62B-9308-4ED0-9F7A-E0FE1C79A638

Q33395970-05272483-99B5-43D9-9091-F015154D5281

Q33395970-0591260E-52F2-46CA-873D-2F0B6C01B495

Q33395970-05AC7FE1-8E44-4BAF-88CD-B9E408161414

Q33395970-081BEC45-CB47-42E5-B72C-A97443FD4F2C

Q33395970-0AFB2FF6-5992-41ED-8D74-B95AEFD14AF4

Q33395970-0B154275-5769-4F4E-9888-A8E5243C10C8

Q33395970-0C6C32DF-D73D-4250-8989-9DBB96E14DDA

Q33395970-110B64AF-13F8-416F-BA52-526F807D131B

Q33395970-1294E950-18E1-421F-B2FE-ED3F2028F054

P304

Q33395970-310C2A23-6895-4C0D-B772-40C504A7C9A1

P31

Q33395970-1AE7206D-9658-4F2A-8043-9FF493C789E1

P356

Q33395970-993DBAC0-D598-4FEA-A5EE-219A93474680

P433

Q33395970-187535EE-F552-4AE0-8C52-65905A00B9D2

P478

Q33395970-690C2EFA-12BA-4DEB-9F54-714836FEAD40

P577

Q33395970-546F104D-0B4C-451A-922C-D09064B07B2B

P5875

Q33395970-93D5E95B-F637-43F5-BC72-1CC31501DDC8

P698

Q33395970-11FC1598-FD11-4FE6-8335-41CF1D74F000

P921

Q33395970-5538F89E-CC93-45E4-A93F-39B76AAFA3C6

P932

Q33395970-E6E20EA0-C1FB-4559-9723-055940C73594

P356

P1433

Stem Cells and Development

P1476

Favorable response of chronic ...... pura to mesenchymal stem cells

@en

P2093

Baijun Fang

http://www.w3.org/2001/XMLSchema#string

Ling Mai

http://www.w3.org/2001/XMLSchema#string

Ning Li

http://www.w3.org/2001/XMLSchema#string

Yongping Song

http://www.w3.org/2001/XMLSchema#string

P2860

Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody

Increased antiplatelet T helper lymphocyte reactivity in patients with autoimmune thrombocytopenia

Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity

Human mesenchymal stem cells modulate allogeneic immune cell responses

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

The cellular immunology associated with autoimmune thrombocytopenic purpura: an update.

Plasma-soluble Fas (APO-1, CD95) and soluble Fas ligand in immune thrombocytopenic purpura.

A transforming growth factor-beta1-mediated bystander immune suppression could be associated with remission of chronic idiopathic thrombocytopenic purpura.

A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia.

Morbidity and mortality in adults with idiopathic thrombocytopenic purpura.

P304

497-502

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/SCD.2011.0231

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51450149

http://www.w3.org/2001/XMLSchema#string

P698

21711157

http://www.w3.org/2001/XMLSchema#string

P921

thrombocytopenia

P932

3272240

http://www.w3.org/2001/XMLSchema#string